Price Alert

Pieris Pharmaceuticals In... (PIRS)

NASDAQ: PIRS · Real-Time Price · USD

13.60

-2.51 (-15.58%)

At close: Dec 13, 2024, 10:00 PM

Pieris Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	75.63M	83.6M	19.36M	19.73M	19.08M	17.4M	32.89M	44.94M	39.74M	38.63M	48.42M	54.26M	83.74M	117.76M	125.05M	119.1M	66.83M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	8.97M	11.92M	9.94M	8.64M	20.53M	21.4M	26.68M	16.53M	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.81M	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	-1.7M	1.09M	1.25M	1.37M	1.31M	2.36M	2.67M	2.9M	1.14M	3.12M	3.21M
Receivables	n/a	358K	879K	4.67M	7.25M	2.9M	1.04M	952K	1.05M	5.81M	829K	1.26M	1.64M	3.31M	6.65M	2.8M	15.81M
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	2.1M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	3.81M	4.27M	280K	649K	3.17M	7.66M	13.23M	10.64M	11.07M	8.45M	7.91M	8.7M	9.84M	6.55M	5.95M	5.77M	5.63M
Total Current Assets	79.44M	88.23M	20.52M	25.05M	29.5M	38.68M	59.09M	66.47M	60.51M	73.42M	78.56M	90.9M	111.75M	127.63M	137.65M	127.67M	88.27M
Property-Plant & Equipment	n/a	n/a	n/a	n/a	196K	n/a	1.98M	19.98M	20.5M	20.7M	19.3M	21.05M	22.69M	23.03M	23.59M	24.23M	24.3M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	n/a	n/a	n/a	196K	n/a	287K	21.07M	21.75M	22.07M	20.6M	23.41M	25.37M	25.93M	26.54M	27.36M	27.51M
Total Assets	79.44M	88.23M	20.52M	25.05M	29.5M	38.68M	59.38M	87.54M	82.26M	95.49M	99.16M	114.31M	137.12M	153.56M	164.18M	155.03M	115.79M
Account Payables	4.44M	4.59M	801K	969K	1.52M	3.37M	2.82M	7.6M	5.83M	4.15M	3.64M	1.9M	4.5M	8.61M	3.56M	2.31M	3.47M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	994K	17.68M	26.69M	20.82M	18.5M	22.86M	20.91M	25.12M	26.45M	25.54M	17.24M
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	12.29M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	4.54M	7.45M	3.4M	1.04M	557K	2.1M	-1.63M	6.05M	7.79M	7.73M	7.31M	7.41M	10.62M	12.21M	15.74M	12.87M	7.1M
Total Current Liabilities	8.98M	12.04M	4.25M	6.35M	7.53M	11.92M	28.87M	34.37M	42.88M	36.58M	33.52M	35.55M	39.48M	50.56M	49.7M	43.93M	30.27M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	14.88M	13.59M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	14.88M	13.59M	n/a	n/a	n/a	n/a	n/a	12.68M	23.93M	30.98M	29.88M	34.4M	44.18M	52.24M	60.63M	64.38M	47.28M
Total Liabilities	23.86M	25.63M	4.25M	6.35M	7.53M	11.92M	28.87M	47.05M	66.8M	67.56M	63.4M	69.94M	83.67M	102.81M	110.33M	108.31M	77.55M
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a	12.29M	12.83M	12.2M	13.1M	12.22M	13.25M	14.37M	14.89M	15.48M	15.92M	15.96M
Common Stock	11K	11K	1K	1K	1K	98K	99K	99K	74K	74K	74K	74K	74K	72K	72K	67K	60K
Retained Earnings	-101.92M	-93.73M	-326.33M	-323.45M	-319.86M	-314.96M	-310.38M	-299.63M	-303.6M	-290.42M	-282.32M	-272.58M	-262.25M	-257.14M	-247.61M	-231.08M	-215.58M
Comprehensive Income	-3K	3K	-316K	-436K	-346K	28K	-339K	-137K	-426K	-254K	524K	625K	953K	829K	616K	234K	194K
Shareholders Equity	55.58M	62.61M	16.27M	18.7M	21.96M	26.76M	30.51M	40.5M	15.46M	27.93M	35.77M	44.37M	53.45M	50.76M	53.85M	46.72M	38.24M
Total Investments	n/a	n/a	n/a	n/a	n/a	8.97M	11.92M	9.94M	8.64M	20.53M	21.4M	26.68M	16.53M	n/a	1.81M	n/a	n/a